vendredi 29 janvier 2016

Onco Actu du 29 janvier 2016

1. Biologie

A cancer’s surprise origins, caught in action [Harvard Gazette]

Cancer drug target visualized at atomic resolution [National Institutes of Health]

A Single Cell Shines New Light on How Cancers Develop [NY Times]

4.2 Dép., diag. & prono. - Génome

Broad genetic testing for childhood cancer patients can pinpoint cancer causes and identify potential treatments [Baylor College of Medicine]

4.5 Dép., diag. & prono. - Colorectal

Health news headscratcher: How did a message about colonoscopies turn a full 180 degrees? [HealthNewsReview]

5.12 Immunothérapies

CRISPR: The Path to Clinical Trials [Xconomy]

5.2 Pharma

AZ’s Lynparza gets prostate cancer breakthrough status [Pharmafile]

CheckMate -141, a Pivotal Phase 3 Opdivo (nivolumab) Head and Neck Cancer Trial, Stopped Early [BMS]

5.2.1 Pharma - Partenariats

Merck bets up to $515M on an epigenetic project for cancer and blood disease [FierceBiotech]

5.3.4 Traitements - AMM (FDA, EMA)

FDA Approves First Drug to Improve Overall Survival in Liposarcoma [RAPS]

FDA approves first drug to show survival benefit in liposarcoma [FDA]

FDA approves Eisai's drug Halaven for type of soft tissue cancer [Reuters]

5.4 Traitements - Economie

The top 10 (possible) blockbusters that (might) launch this year [FierceBiotech]

Roche expects cancer treatments to be spared U.S. pricing curbs [Reuters]

Representatives Send Letter to HHS and NIH Seeking Response to Pharmaceutical Costs [Patent Docs]

6.1 Observation

Poor or Minority Adolescent and Young Adult Patients Are Less Likely to Beat Hodgkin Lymphoma [AACR]

6.10 Politiques

Joe Biden's cancer task force to start work next week [STAT]

Obama’s cancer challenge and the audacity of hope [The Institute of Cancer Research]

Experts Forecast Cancer Research and Treatment Advances in 2016 [CANCER RESEARCH Catalyst]

ASCO Praises President for White House’s Support of “Moonshot” Initiative [ASCO]

Obama to Take First Step in a Cancer ‘Moonshot’ [NY Times]

The Cancer Moonshot Task Force: Removing Bureaucratic Hurdles and Supporting Scientific Advances [Medium]

6.6 Publications

Sharing data is a good thing. But we need to consider the costs. [Retraction Watch]

6.7 DMP, Big Data & applis

Unique patient identifier: Experts argue the benefits, pitfalls [STAT]

6.8 Communication

Cancer is happening right now: a winning campaign that hits home [The Guardian]

6.9 Controverses

DuPont faces 40 trials a year over cancer tied to Teflon chemical [Reuters]